Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome

被引:28
作者
Wiedermann, FJ
Mayr, AJ
Hobisch-Hagen, P
Fuchs, D
Schobersberger, W
机构
[1] Leopold Franzens Univ Innsbruck, Dept Anesthesiol & Crit Care Med, A-6020 Innsbruck, Austria
[2] Leopold Franzens Univ Innsbruck, Dept Chem & Biochem, A-6020 Innsbruck, Austria
关键词
D O I
10.1089/107999003772084842
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Upregulation of the anti-inflammatory mediators, soluble tumor necrosis factor-a receptors I and II (sTNF-RI/RII) and interleukin-1 receptor antagonist (IL-1RA), by granulocyte colony-stimulating factor (G-CSF) may contribute to the pathophysiology of lung injury. We determined the relation of endogenous G-CSF to proinflammatory and anti-inflammatory mediators in bronchoalveolar lavage fluid (BALF) and serum of patients with acute respiratory distress syndrome (ARDS) and acute lung injury (ALI). Nineteen patients with ARDS and 10 with ALI were included in this prospective investigation. BAL was performed within 12 h and 24 h after onset of lung injury. Concentrations of G-CSF, TNF-alpha, IL-6, sTNFRI and sTNFRII, IL-1RA and IL-10 in BALF as well as in serum were determined by ELISA. G-CSF was associated with alveolar neutrophilia. Results in patients with ARDS and ALI exhibited significant positive correlations in BALF of G-CSF levels with that of IL-6, sTNFRII, and IL-1RA and of G-CSF levels in serum with that of serum IL-6, IL-1RA, and IL-10. Given the potential of G-CSF to directly induce anti-inflammatory cytokines in vitro, significant associations of endogenous G-CSF levels with these mediators early in the development of severe lung injury suggest an endogenous anti-inflammatory role of G-CSF in vivo.
引用
收藏
页码:729 / 736
页数:8
相关论文
共 41 条
  • [1] G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome
    Aggarwal, A
    Baker, CS
    Evans, TW
    Haslam, PL
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (05) : 895 - 901
  • [2] THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION
    BERNARD, GR
    ARTIGAS, A
    BRIGHAM, KL
    CARLET, J
    FALKE, K
    HUDSON, L
    LAMY, M
    LEGALL, JR
    MORRIS, A
    SPRAGG, R
    COCHIN, B
    LANKEN, PN
    LEEPER, KV
    MARINI, J
    MURRAY, JF
    OPPENHEIMER, L
    PESENTI, A
    REID, L
    RINALDO, J
    VILLAR, J
    VANASBECK, BS
    DHAINAUT, JF
    MANCEBO, J
    MATTHAY, M
    MEYRICK, B
    PAYEN, D
    PERRET, C
    FOWLER, AA
    SCHALLER, MD
    HUDSON, LD
    HYERS, T
    KNAUS, W
    MATTHAY, R
    PINSKY, M
    BONE, RC
    BOSKEN, C
    JOHANSON, WG
    LEWANDOWSKI, K
    REPINE, J
    RODRIGUEZROISIN, R
    ROUSSOS, C
    ANTONELLI, MA
    BELOUCIF, S
    BIHARI, D
    BURCHARDI, H
    LEMAIRE, F
    MONTRAVERS, P
    PETTY, TL
    ROBOTHAM, J
    ZAPOL, W
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) : 818 - 824
  • [3] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [4] Proinflammatory cytokines
    Dinarello, CA
    [J]. CHEST, 2000, 118 (02) : 503 - 508
  • [5] The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome
    Donnelly, SC
    Strieter, RM
    Reid, PT
    Kunkel, SL
    Burdick, MD
    Armstrong, I
    Mackenzie, A
    Haslett, C
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (03) : 191 - +
  • [6] Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor
    Ericson, SG
    Zhao, Y
    Gao, HL
    Miller, KL
    Gibson, LF
    Lynch, JP
    Landreth, KS
    [J]. BLOOD, 1998, 91 (06) : 2099 - 2107
  • [7] EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR ON SYSTEMIC AND PULMONARY RESPONSES TO ENDOTOXIN IN PIGS
    FINK, MP
    OSULLIVAN, BP
    MENCONI, MJ
    WOLLERT, SP
    WANG, HL
    YOUSSEF, ME
    BELLELSLE, JM
    SUGERMAN, H
    DEMLING, RH
    MARZI, I
    HORN, JK
    DEITCH, EA
    FABIAN, TC
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1993, 34 (04) : 571 - 578
  • [8] Hannen M, 1999, SCAND J IMMUNOL, V50, P461
  • [9] Induction and regulation of endogenous granulocyte colony-stimulating factor formation
    Hareng, L
    Hartung, T
    [J]. BIOLOGICAL CHEMISTRY, 2002, 383 (10) : 1501 - 1517
  • [10] EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR TREATMENT ON EX-VIVO BLOOD CYTOKINE RESPONSE IN HUMAN VOLUNTEERS
    HARTUNG, T
    DOCKE, WD
    GANTNER, F
    KRIEGER, G
    SAUER, A
    STEVENS, P
    VOLK, HD
    WENDEL, A
    [J]. BLOOD, 1995, 85 (09) : 2482 - 2489